Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2011 Nov 9;67(Pt 12):m1736–m1737. doi: 10.1107/S1600536811046940

Calcium acamprosate: a triclinic polymorph

Elisabetta Maccaroni a, Walter Panzeri b, Luciana Malpezzi a,*
PMCID: PMC3238647  PMID: 22199538

Abstract

The title compound, poly[bis­(μ3-4-acetamido­propane­sulfon­ato)­calcium], [Ca(C5H10NO4S)2]n, is a triclinic polymorph of the previously reported monoclinic structure [Toffoli et al. (1988). Acta Cryst. C44, 1493–1494]. The triclinic modification was found to have an all-trans configuration of the acetamido­propane chain, in contrast with the monoclinic polymorph which shows an angle of 74.66 (8)° between the S—C—C—C chain plane and that of the amide group. The Ca2+ cation is situated on an inversion centre and is hexa­coordinated by six O atoms belonging to different anions in a distorted octa­hedral geometry. This arrangement leads to a layered structure parallel to (011). The layers are held together by N—H⋯O hydrogen bonds and by short C—H⋯O inter­actions, both involving the sulfonate O atoms not coordinated to the Ca2+ cations. The structure was determined from a crystal twinned by non-merohedry [twin law (Inline graphic00, 0Inline graphic0, −0.335 −0.85 1), with a fractional contribution of the minor twin domain of 46.7 (1)%].

Related literature

For the characterization of the monclinic polymorph and related structures, see: Toffoli et al. (1988). The title compound is a drug used successfully in the treatment of alcoholism. For the synthesis, see: Laboratorio Chimico Inter­nazionale SpA (2010). For its therapeutic effect and a tolerability study, see: Rösner et al. (2010). For proposed mechanisms of action, see: De Witte et al. (2005). Programs used for identifying the twin system were PLATON (Spek, 2009) and CELL_NOW (Bruker, 2008). For standard bond lengths, see: Allen et al. (1987).graphic file with name e-67-m1736-scheme1.jpg

Experimental

Crystal data

  • [Ca(C5H10NO4S)2]

  • M r = 400.48

  • Triclinic, Inline graphic

  • a = 5.5372 (4) Å

  • b = 8.1487 (6) Å

  • c = 9.7578 (7) Å

  • α = 69.159 (1)°

  • β = 84.305 (2)°

  • γ = 89.329 (2)°

  • V = 409.31 (5) Å3

  • Z = 1

  • Mo Kα radiation

  • μ = 0.68 mm−1

  • T = 293 K

  • 0.29 × 0.23 × 0.08 mm

Data collection

  • Bruker SMART APEX CCD diffractometer

  • Absorption correction: multi-scan (TWINABS; Bruker, 2008) T min = 0.827, T max = 0.948

  • 22542 measured reflections

  • 8721 independent reflections

  • 7647 reflections with I > 2σ(I)

  • R int = 0.027

Refinement

  • R[F 2 > 2σ(F 2)] = 0.034

  • wR(F 2) = 0.088

  • S = 1.02

  • 8721 reflections

  • 109 parameters

  • H-atom parameters constrained

  • Δρmax = 0.39 e Å−3

  • Δρmin = −0.33 e Å−3

Data collection: SMART (Bruker, 2003); cell refinement: SAINT (Bruker, 2003); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL/NT (Sheldrick, 2008); software used to prepare material for publication: SHELXL97.

Supplementary Material

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811046940/zl2412sup1.cif

e-67-m1736-sup1.cif (19.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811046940/zl2412Isup2.hkl

e-67-m1736-Isup2.hkl (426.6KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
N—H1N⋯O1i 0.86 2.15 3.0025 (12) 169
C5—H5C⋯O1i 0.96 2.48 3.3569 (15) 152
C1—H1B⋯O1ii 0.97 2.53 3.3007 (14) 137

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Acknowledgments

Samples of the title compound were kindly provided by Laboratorio Chimico Inter­nazionale SpA (Via T. Salvini 10, I-20122 Milan, Italy).

supplementary crystallographic information

Comment

Calcium acamprosate (Fig. 1), systematic name: calcium bis(3-acetylamino-propane)-1-sulphonate, also known as N-acetyl homotaurine, is a white crystalline synthetic compound which crystallizes as discrete acetylamino-propane-sulphonate anions, (C5H10N O4S)-, and Ca2+ cations, connected by Ca···O interactions. It is used in the treatment of alcoholism and it is specifically indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence (Rösner et al., 2010). The mechanism of action of calcium acamprosate in prevention of relapses is not completely understood, but it is believed to restore the normal chemical balance between neuronal excitation and inhibition that would be disrupted by long-term or chronic alcohol abuse. In other words, it helps the brain begin working normally again (De Witte et al., 2005).

A monoclinic polymorph (A) of the title compound has been previously reported (Toffoli et al. 1988). The new polymorph form (B) crystallizes in the centrosymmetric P1 space group with the Ca2+ located on a crystallographic inversion centre, so there is only one single anion in the asymmetric unit of the elementary cell. The conformation of the acetylamino-propane chain shows the main geometric difference between polymorph A and polymorph B: in the triclinic modification (B) the conformation is all trans, while in the monoclinic form (A) an angle of 74.66 (8)° between the S—C—C—C chain plane and that of the amide group was found. Bond lengths and angles are within normal ranges (Allen et al., 1987) and are comparable with those of polymorph (A). Each Ca2+ cation is coordinated in a distorted octahedral geometry to six different anions via Ca···O interactions with four sulfonyl O atoms and two carbonyl O atoms with a Ca···O distance in the range 2.283 (1)–2.394 (1) Å. The coordination of the Ca2+ cations to two terminal sides of the anions leads to a polymeric bidimensional structure extended in layers parallel to the (011) plane. The layers are connected into a three-dimensional network by N—H···O hydrogen bonds and by short C—H···O interactions, both involving the sulfonyl O atoms not coordinated to the Ca2+ cations.

Experimental

The title compound was prepared according to the procedure patented by Laboratorio Chimico Internazionale SpA (2010). Polymorph B precipitates by adding 500 ml of isopropyl alcohol to a water solution of calcium acamprosate kept at 348–353 K and stirred for 53 h. The white solid obtained was filtered hot (348–353 K) and purified by washing with 300 ml of a 75/25 solution (preheated to 343 K) of isopropyl alcohol and deionized water. The wet product was dried under reduced pressure for 6 h at 318 K. Some crystals were suitable for single-crystal XR analysis. The XRPD pattern, carried out on the crystalline powder of this product, is completely in agreement with the powder pattern calculated from the data obtained by single-crystal XR analysis, thus confirming the purity of the crystalline phase of the batch.

Refinement

The crystal under investigation was found to be non-merohedrally twinned. All reflections for both domains (10284 total) were integrated using Saint, obtaining a number of 4143 reflections (1692 unique ones) for component 1 only (mean I/σ = 12.3), 4146 reflections (1702 unique ones) for component 2 only (mean I/σ = 12.1) and 1974 reflections (929 unique ones) involving both components (mean I/σ = 16.7). The twin law (-1 0 0 0 - 1 0 - 0.335 - 0.85 1) was obtained by the TwinRotMat routine of the PLATON software (Spek, 2009). The orientation matrices for the two components were identified using the program CELL_NOW (Bruker, 2008), with the two twin components resulting related by a 180° rotation around the reciprocal c axis. The reflection data were corrected for absorption using TWINABS (Bruker, 2008), obtaining the HKLF-5 type list of reflections (Sheldrick, 2008) with twin-contributor indicators. The structure was solved using direct methods with only the non-overlapping reflections of component 1 and refined with all reflections of component 1, including the overlapping ones. The fractional contribution of the minor twin component refined to 46.7 (1). H atoms were placed in calculated positions and refined in a riding model with C—H distances of 0.96–0.97 Å and and N—H distance of 0.86 Å. All H atoms were refined with Uiso(H) values equal to 1.5 Ueq of the carrier atom for the methyl group and 1.2 Ueq for all remaining atoms.

Figures

Fig. 1.

Fig. 1.

A view of the calcium acamprosate salt (B), showing the anion and cation of the asymmetric unit and the second anion, labeled with a prime symbol, generated by the symmetry operation [1 - x, 2 - y, 1 - z], to complete the unit formula.

Fig. 2.

Fig. 2.

A view of the crystal packing of calcium acamprosate (B), showing a layer of the two dimensional structure running parallel to the (011) plane.

Fig. 3.

Fig. 3.

Crystal packing of calcium acamprosate (B), viewed along a axis. N—H···O1 hydrogen bonds and C—H···O1 short interactions are shown as dashed lines.

Crystal data

[Ca(C5H10NO4S)2] Z = 1
Mr = 400.48 F(000) = 210
Triclinic, P1 Dx = 1.625 Mg m3
Hall symbol: -P 1 Mo Kα radiation, λ = 0.71069 Å
a = 5.5372 (4) Å Cell parameters from 4793 reflections
b = 8.1487 (6) Å θ = 2.3–27.1°
c = 9.7578 (7) Å µ = 0.68 mm1
α = 69.159 (1)° T = 293 K
β = 84.305 (2)° Plate, colourless
γ = 89.329 (2)° 0.29 × 0.23 × 0.08 mm
V = 409.31 (5) Å3

Data collection

Bruker SMART APEX CCD diffractometer 8721 independent reflections
Radiation source: fine-focus sealed tube 7647 reflections with I > 2σ(I)
graphite Rint = 0.027
ω scans θmax = 27.5°, θmin = 2.2°
Absorption correction: multi-scan (TWINABS; Bruker, 2008) h = −7→7
Tmin = 0.827, Tmax = 0.948 k = −10→10
22542 measured reflections l = −12→12

Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.034 Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.088 H-atom parameters constrained
S = 1.02 w = 1/[σ2(Fo2) + (0.0478P)2] where P = (Fo2 + 2Fc2)/3
8721 reflections (Δ/σ)max = 0.006
109 parameters Δρmax = 0.39 e Å3
0 restraints Δρmin = −0.33 e Å3

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Ca 1.0000 0.5000 0.0000 0.02008 (8)
S 0.46696 (4) 0.53055 (3) 0.23925 (3) 0.02053 (7)
O1 0.39518 (14) 0.65813 (9) 0.30610 (8) 0.03333 (19)
O2 0.71997 (12) 0.55429 (9) 0.17559 (8) 0.02862 (18)
O3 0.30448 (15) 0.52304 (11) 0.13414 (8) 0.0383 (2)
O4 0.06178 (14) −0.20198 (9) 0.83520 (8) 0.0340 (2)
N −0.01015 (17) 0.07771 (11) 0.69942 (10) 0.0334 (2)
H1N −0.1087 0.1630 0.6866 0.040*
C1 0.44992 (19) 0.32245 (13) 0.38187 (11) 0.0257 (2)
H1A 0.4796 0.2327 0.3388 0.031*
H1B 0.5769 0.3165 0.4450 0.031*
C2 0.20568 (19) 0.28297 (13) 0.47557 (12) 0.0282 (2)
H2A 0.1742 0.3719 0.5193 0.034*
H2B 0.0776 0.2860 0.4138 0.034*
C3 0.20577 (19) 0.10418 (14) 0.59580 (12) 0.0305 (3)
H3A 0.2108 0.0138 0.5524 0.037*
H3B 0.3493 0.0946 0.6474 0.037*
C4 −0.0642 (2) −0.07020 (14) 0.81257 (12) 0.0294 (3)
C5 −0.2877 (2) −0.07026 (17) 0.91136 (14) 0.0541 (4)
H5A −0.2469 −0.0998 1.0105 0.081*
H5B −0.4034 −0.1553 0.9080 0.081*
H5C −0.3566 0.0442 0.8791 0.081*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Ca 0.01787 (15) 0.02063 (15) 0.01751 (15) −0.00083 (11) 0.00031 (11) −0.00214 (12)
S 0.01931 (13) 0.02153 (13) 0.01727 (13) −0.00037 (10) 0.00084 (10) −0.00333 (10)
O1 0.0406 (5) 0.0242 (4) 0.0332 (4) 0.0049 (3) 0.0042 (4) −0.0100 (3)
O2 0.0207 (4) 0.0316 (4) 0.0274 (4) −0.0034 (3) 0.0064 (3) −0.0052 (3)
O3 0.0328 (4) 0.0520 (5) 0.0267 (4) −0.0053 (4) −0.0088 (4) −0.0081 (4)
O4 0.0360 (5) 0.0221 (4) 0.0337 (5) 0.0035 (3) 0.0052 (4) 0.0001 (3)
N 0.0362 (6) 0.0223 (5) 0.0295 (5) 0.0062 (4) 0.0106 (4) 0.0018 (4)
C1 0.0271 (6) 0.0208 (5) 0.0229 (5) 0.0011 (4) 0.0026 (5) −0.0016 (4)
C2 0.0254 (6) 0.0244 (6) 0.0265 (6) −0.0001 (4) 0.0047 (5) −0.0006 (5)
C3 0.0309 (6) 0.0235 (6) 0.0284 (6) −0.0001 (4) 0.0065 (5) −0.0011 (5)
C4 0.0339 (6) 0.0225 (6) 0.0247 (6) −0.0003 (5) 0.0047 (5) −0.0019 (5)
C5 0.0578 (9) 0.0355 (7) 0.0443 (8) 0.0108 (6) 0.0261 (7) 0.0076 (6)

Geometric parameters (Å, °)

Ca—O3i 2.2828 (8) N—C3 1.4523 (13)
Ca—O3ii 2.2828 (8) N—H1N 0.8600
Ca—O2iii 2.3519 (7) C1—C2 1.5245 (13)
Ca—O2 2.3519 (7) C1—H1A 0.9700
Ca—O4iv 2.3941 (7) C1—H1B 0.9700
Ca—O4v 2.3941 (7) C2—C3 1.5109 (14)
S—O1 1.4442 (7) C2—H2A 0.9700
S—O3 1.4471 (8) C2—H2B 0.9700
S—O2 1.4609 (7) C3—H3A 0.9700
S—C1 1.7662 (10) C3—H3B 0.9700
O3—Cavi 2.2828 (8) C4—C5 1.4910 (16)
O4—C4 1.2382 (12) C5—H5A 0.9600
O4—Cavii 2.3941 (7) C5—H5B 0.9600
N—C4 1.3256 (13) C5—H5C 0.9600
O3i—Ca—O3ii 180.00 (4) C2—C1—S 113.33 (7)
O3i—Ca—O2iii 88.69 (3) C2—C1—H1A 108.9
O3ii—Ca—O2iii 91.31 (3) S—C1—H1A 108.9
O3i—Ca—O2 91.31 (3) C2—C1—H1B 108.9
O3ii—Ca—O2 88.69 (3) S—C1—H1B 108.9
O2iii—Ca—O2 180.000 (1) H1A—C1—H1B 107.7
O3i—Ca—O4iv 92.36 (3) C3—C2—C1 110.28 (8)
O3ii—Ca—O4iv 87.64 (3) C3—C2—H2A 109.6
O2iii—Ca—O4iv 97.35 (3) C1—C2—H2A 109.6
O2—Ca—O4iv 82.65 (3) C3—C2—H2B 109.6
O3i—Ca—O4v 87.64 (3) C1—C2—H2B 109.6
O3ii—Ca—O4v 92.36 (3) H2A—C2—H2B 108.1
O2iii—Ca—O4v 82.65 (3) N—C3—C2 110.46 (8)
O2—Ca—O4v 97.35 (3) N—C3—H3A 109.6
O4iv—Ca—O4v 180.00 (2) C2—C3—H3A 109.6
O1—S—O3 112.42 (5) N—C3—H3B 109.6
O1—S—O2 112.71 (5) C2—C3—H3B 109.6
O3—S—O2 111.72 (5) H3A—C3—H3B 108.1
O1—S—C1 107.12 (5) O4—C4—N 122.27 (10)
O3—S—C1 106.99 (5) O4—C4—C5 121.44 (10)
O2—S—C1 105.35 (5) N—C4—C5 116.28 (9)
S—O2—Ca 144.39 (5) C4—C5—H5A 109.5
S—O3—Cavi 170.63 (5) C4—C5—H5B 109.5
C4—O4—Cavii 132.62 (7) H5A—C5—H5B 109.5
C4—N—C3 123.86 (9) C4—C5—H5C 109.5
C4—N—H1N 118.1 H5A—C5—H5C 109.5
C3—N—H1N 118.1 H5B—C5—H5C 109.5
O1—S—O2—Ca −156.68 (7) O2—S—C1—C2 172.54 (8)
O3—S—O2—Ca −28.97 (9) S—C1—C2—C3 −179.41 (8)
C1—S—O2—Ca 86.85 (8) C4—N—C3—C2 176.87 (11)
O3i—Ca—O2—S 23.48 (8) C1—C2—C3—N 170.74 (9)
O3ii—Ca—O2—S −156.52 (8) Cavii—O4—C4—N −169.56 (8)
O4iv—Ca—O2—S −68.73 (8) Cavii—O4—C4—C5 9.90 (18)
O4v—Ca—O2—S 111.27 (8) C3—N—C4—O4 −3.33 (19)
O1—S—C1—C2 52.32 (9) C3—N—C4—C5 177.18 (11)
O3—S—C1—C2 −68.44 (9)

Symmetry codes: (i) −x+1, −y+1, −z; (ii) x+1, y, z; (iii) −x+2, −y+1, −z; (iv) −x+1, −y, −z+1; (v) x+1, y+1, z−1; (vi) x−1, y, z; (vii) x−1, y−1, z+1.

Hydrogen-bond geometry (Å, °)

D—H···A D—H H···A D···A D—H···A
N—H1N···O1viii 0.86 2.15 3.0025 (12) 169.
C5—H5C···O1viii 0.96 2.48 3.3569 (15) 152.
C1—H1B···O1ix 0.97 2.53 3.3007 (14) 137.

Symmetry codes: (viii) −x, −y+1, −z+1; (ix) −x+1, −y+1, −z+1.

Footnotes

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: ZL2412).

References

  1. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–19.
  2. Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115–119.
  3. Bruker (2003). SMART and SAINT Bruker AXS Inc., Madison, Wisconsin, USA.
  4. Bruker (2008). CELL_NOW and TWINABS Bruker AXS Inc., Madison, Wisconsin, USA.
  5. De Witte, P., Littleton, J., Parot, P. & Koob, G. (2005). CNS Drugs, 19, 517–537. [DOI] [PubMed]
  6. Laboratorio Chimico Internazionale SpA (2010). Patent No. WO2010/035094.
  7. Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S. & Soyka, M. (2010). Cochrane Database Syst. Rev. 9, 1–119. [DOI] [PMC free article] [PubMed]
  8. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  9. Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
  10. Toffoli, P., Rodier, N., Ceolin, R., Ladure, P. & Tran, G. (1988). Acta Cryst. C44, 1493–1494.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811046940/zl2412sup1.cif

e-67-m1736-sup1.cif (19.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811046940/zl2412Isup2.hkl

e-67-m1736-Isup2.hkl (426.6KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES